ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,000 | +25.0% | 6,554 | +61.0% | 0.00% | – |
| Q2 2023 | $32,000 | – | 4,071 | +67750.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 6 | -96.9% | 0.00% | – |
| Q4 2022 | $1,000 | -66.7% | 191 | -82.4% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 1,087 | +110.3% | 0.00% | – |
| Q2 2022 | $2,000 | -90.5% | 517 | -86.9% | 0.00% | – |
| Q1 2022 | $21,000 | -76.7% | 3,942 | -35.4% | 0.00% | – |
| Q4 2021 | $90,000 | +28.6% | 6,099 | +81.0% | 0.00% | – |
| Q3 2021 | $70,000 | +94.4% | 3,370 | +66.8% | 0.00% | – |
| Q2 2021 | $36,000 | -26.5% | 2,020 | +1.5% | 0.00% | – |
| Q1 2021 | $49,000 | +188.2% | 1,991 | +291.2% | 0.00% | – |
| Q4 2020 | $17,000 | +1600.0% | 509 | +2323.8% | 0.00% | – |
| Q3 2020 | $1,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,007,576 | $25,199,000 | 12.12% |
| Svennilson Peter | 4,768,181 | $119,252,000 | 9.73% |
| EcoR1 Capital, LLC | 2,642,218 | $66,082,000 | 4.71% |
| Orbimed Advisors | 2,921,967 | $73,078,000 | 0.92% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 312,483 | $7,815,000 | 0.35% |
| EMERALD ADVISERS, LLC | 324,582 | $8,118,000 | 0.33% |
| Casdin Capital, LLC | 251,515 | $6,290,000 | 0.28% |
| ArrowMark Colorado Holdings LLC | 995,382 | $24,895,000 | 0.24% |
| Artal Group S.A. | 142,500 | $3,564,000 | 0.09% |
| Alyeska Investment Group, L.P. | 161,585 | $4,041,000 | 0.06% |